158 research outputs found

    Comparison of two nanofiltration membrane reactors for a model reaction of olefin metathesis achieved in toluene

    No full text
    International audienceThe recent commercialisation of nanofiltration membranes resistant toward organic solvents is a real opportunity for fine chemistry. This study deals with different ways of integration of organic solvent nanofiltration for a specific type of reactions known as olefin metathesis and shows the use of two nanofiltration membrane reactors both running in cross-flow filtration mode (0.1 m s- 1). They are used either in semi-continuous or continuous mode. A model ring closing metathesis reaction is chosen for the demonstration. A commercially available pre-catalyst, namely Grubbs-Hoveyda II, as well as a commercial polyimide membrane (Starmem 122, MWCO 220 g mol- 1) are used. Firstly, nanofiltration of the single pre-catalyst allows establishing that the highest retention is obtained with a 40 bar pressure. Secondly, this pressure is used with the two membrane reactors before testing other conditions. Finally, interests and limitations of the two reactors are discussed

    The CXCL12Îł Chemokine Displays Unprecedented Structural and Functional Properties that Make It a Paradigm of Chemoattractant Proteins

    Get PDF
    The CXCL12Îł chemokine arises by alternative splicing from Cxcl12, an essential gene during development. This protein binds CXCR4 and displays an exceptional degree of conservation (99%) in mammals. CXCL12Îł is formed by a protein core shared by all CXCL12 isoforms, extended by a highly cationic carboxy-terminal (C-ter) domain that encompass four overlapped BBXB heparan sulfate (HS)-binding motifs. We hypothesize that this unusual domain could critically determine the biological properties of CXCL12Îł through its interaction to, and regulation by extracellular glycosaminoglycans (GAG) and HS in particular. By both RT-PCR and immunohistochemistry, we mapped the localization of CXCL12Îł both in mouse and human tissues, where it showed discrete differential expression. As an unprecedented feature among chemokines, the secreted CXCL12Îł strongly interacted with cell membrane GAG, thus remaining mostly adsorbed on the plasmatic membrane upon secretion. Affinity chromatography and surface plasmon resonance allowed us to determine for CXCL12Îł one of the higher affinity for HS (Kd = 0.9 nM) ever reported for a protein. This property relies in the presence of four canonical HS-binding sites located at the C-ter domain but requires the collaboration of a HS-binding site located in the core of the protein. Interestingly, and despite reduced agonist potency on CXCR4, the sustained binding of CXCL12Îł to HS enabled it to promote in vivo intraperitoneal leukocyte accumulation and angiogenesis in matrigel plugs with much higher efficiency than CXCL12α. In good agreement, mutant CXCL12Îł chemokines selectively devoid of HS-binding capacity failed to promote in vivo significant cell recruitment. We conclude that CXCL12Îł features unique structural and functional properties among chemokines which rely on the presence of a distinctive C-ter domain. The unsurpassed capacity to bind to HS on the extracellular matrix would make CXCL12Îł the paradigm of haptotactic proteins, which regulate essential homeostatic functions by promoting directional migration and selective tissue homing of cells

    Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

    Full text link
    Life-threatening `breakthrough' cases of critical COVID-19 are attributed to poor or waning antibody response to the SARS- CoV-2 vaccine in individuals already at risk. Pre-existing autoantibodies (auto-Abs) neutralizing type I IFNs underlie at least 15% of critical COVID-19 pneumonia cases in unvaccinated individuals; however, their contribution to hypoxemic breakthrough cases in vaccinated people remains unknown. Here, we studied a cohort of 48 individuals ( age 20-86 years) who received 2 doses of an mRNA vaccine and developed a breakthrough infection with hypoxemic COVID-19 pneumonia 2 weeks to 4 months later. Antibody levels to the vaccine, neutralization of the virus, and auto- Abs to type I IFNs were measured in the plasma. Forty-two individuals had no known deficiency of B cell immunity and a normal antibody response to the vaccine. Among them, ten (24%) had auto-Abs neutralizing type I IFNs (aged 43-86 years). Eight of these ten patients had auto-Abs neutralizing both IFN-a2 and IFN-., while two neutralized IFN-omega only. No patient neutralized IFN-ss. Seven neutralized 10 ng/mL of type I IFNs, and three 100 pg/mL only. Seven patients neutralized SARS-CoV-2 D614G and the Delta variant (B.1.617.2) efficiently, while one patient neutralized Delta slightly less efficiently. Two of the three patients neutralizing only 100 pg/mL of type I IFNs neutralized both D61G and Delta less efficiently. Despite two mRNA vaccine inoculations and the presence of circulating antibodies capable of neutralizing SARS-CoV-2, auto-Abs neutralizing type I IFNs may underlie a significant proportion of hypoxemic COVID-19 pneumonia cases, highlighting the importance of this particularly vulnerable population

    Multi-messenger observations of a binary neutron star merger

    Get PDF
    On 2017 August 17 a binary neutron star coalescence candidate (later designated GW170817) with merger time 12:41:04 UTC was observed through gravitational waves by the Advanced LIGO and Advanced Virgo detectors. The Fermi Gamma-ray Burst Monitor independently detected a gamma-ray burst (GRB 170817A) with a time delay of ~1.7 s with respect to the merger time. From the gravitational-wave signal, the source was initially localized to a sky region of 31 deg2 at a luminosity distance of 40+8-8 Mpc and with component masses consistent with neutron stars. The component masses were later measured to be in the range 0.86 to 2.26 Mo. An extensive observing campaign was launched across the electromagnetic spectrum leading to the discovery of a bright optical transient (SSS17a, now with the IAU identification of AT 2017gfo) in NGC 4993 (at ~40 Mpc) less than 11 hours after the merger by the One- Meter, Two Hemisphere (1M2H) team using the 1 m Swope Telescope. The optical transient was independently detected by multiple teams within an hour. Subsequent observations targeted the object and its environment. Early ultraviolet observations revealed a blue transient that faded within 48 hours. Optical and infrared observations showed a redward evolution over ~10 days. Following early non-detections, X-ray and radio emission were discovered at the transient’s position ~9 and ~16 days, respectively, after the merger. Both the X-ray and radio emission likely arise from a physical process that is distinct from the one that generates the UV/optical/near-infrared emission. No ultra-high-energy gamma-rays and no neutrino candidates consistent with the source were found in follow-up searches. These observations support the hypothesis that GW170817 was produced by the merger of two neutron stars in NGC4993 followed by a short gamma-ray burst (GRB 170817A) and a kilonova/macronova powered by the radioactive decay of r-process nuclei synthesized in the ejecta

    Multi-messenger Observations of a Binary Neutron Star Merger

    Get PDF
    On 2017 August 17 a binary neutron star coalescence candidate (later designated GW170817) with merger time 12:41:04 UTC was observed through gravitational waves by the Advanced LIGO and Advanced Virgo detectors. The Fermi Gamma-ray Burst Monitor independently detected a gamma-ray burst (GRB 170817A) with a time delay of ∌ 1.7 {{s}} with respect to the merger time. From the gravitational-wave signal, the source was initially localized to a sky region of 31 deg2 at a luminosity distance of {40}-8+8 Mpc and with component masses consistent with neutron stars. The component masses were later measured to be in the range 0.86 to 2.26 {M}ÈŻ . An extensive observing campaign was launched across the electromagnetic spectrum leading to the discovery of a bright optical transient (SSS17a, now with the IAU identification of AT 2017gfo) in NGC 4993 (at ∌ 40 {{Mpc}}) less than 11 hours after the merger by the One-Meter, Two Hemisphere (1M2H) team using the 1 m Swope Telescope. The optical transient was independently detected by multiple teams within an hour. Subsequent observations targeted the object and its environment. Early ultraviolet observations revealed a blue transient that faded within 48 hours. Optical and infrared observations showed a redward evolution over ∌10 days. Following early non-detections, X-ray and radio emission were discovered at the transient’s position ∌ 9 and ∌ 16 days, respectively, after the merger. Both the X-ray and radio emission likely arise from a physical process that is distinct from the one that generates the UV/optical/near-infrared emission. No ultra-high-energy gamma-rays and no neutrino candidates consistent with the source were found in follow-up searches. These observations support the hypothesis that GW170817 was produced by the merger of two neutron stars in NGC 4993 followed by a short gamma-ray burst (GRB 170817A) and a kilonova/macronova powered by the radioactive decay of r-process nuclei synthesized in the ejecta.</p

    SynthĂšses concises de pyrazoles et pyridones diversement fonctionnalisĂ©es dans le but d’effectuer des rĂ©actions de couplages croisĂ©s sĂ©lectifs

    No full text
    This thesis is subdivided into two principal parts. The first part is focussed on the synthesis of pyrazole derivatives of agrochemical relevance. Indeed, the pyrazole nucleus is found in numerous compounds possessing interesting biological properties, and notably antifungal activities. Various convergent approaches to diversely substituted pyrazoles have therefore been developed by means of site-selective palladium-catalyzed cross-coupling reactions conducted sequentially on pyrazole scaffolds. In the second part, we have been involved in the synthesis of furopyridones as simplified analogues of natural compounds possessing antifungal activities such as Cladobotryal. Toward this end, various alkynylpyridones have been synthesizes and involved in diverse cyclization processes to access a series of furo[3,2-c]pyridin-4-ones, furo[3,2-c]pyridin-6-ones, and furo[2,3-b]pyridin-4-onesCe mĂ©moire est subdivise en deux parties. La premiĂšre partie concerne la synthĂšse de pyrazoles prĂ©sentant un intĂ©rĂȘt sur le plan agrochimique. En effet, le noyau pyrazole est prĂ©sent dans de nombreux composes ayant des activitĂ©s biologiques diverses et en particulier antifongique. Au cours de ce travail, nous avons dĂ©veloppĂ© diverses approches convergentes de pyrazoles diversement substituĂ©s au moyen de rĂ©actions de couplages croisĂ©s pallado-catalyses sĂ©lectifs et sĂ©quentiels Ă  partir de pyrazoles possĂ©dant diffĂ©rents points d’encrages. Dans la deuxiĂšme partie, nous nous sommes intĂ©ressĂ©s Ă  la synthĂšse de diverses furopyridones en tant qu’analogues de produits naturels possĂ©dant une activitĂ© antifongique, et notamment le Cladobotryal. Dans ce but, diverses alcynylpyridones ont Ă©tĂ© synthĂ©tisĂ©es et mises en jeu dans divers processus de cyclisation pour atteindre de maniĂšre divergente une sĂ©rie de furo[3,2-c]pyridin-4-ones, furo[3,2-c]pyridin-6-ones et furo[2,3-b]pyridin-4-one

    Modulation de l'expression du GnRH intracellulaire par le calcium, les endopeptidases hypophysaires et la calmoduline

    No full text
    SIGLECNRS T 55516 / INIST-CNRS - Institut de l'Information Scientifique et TechniqueFRFranc

    Efficient syntheses of diversely functionalized pyrazole and pyridone derivatives and their use in siteselective cross-coupling reactions

    No full text
    Ce mĂ©moire est subdivise en deux parties. La premiĂšre partie concerne la synthĂšse de pyrazoles prĂ©sentant un intĂ©rĂȘt sur le plan agrochimique. En effet, le noyau pyrazole est prĂ©sent dans de nombreux composes ayant des activitĂ©s biologiques diverses et en particulier antifongique. Au cours de ce travail, nous avons dĂ©veloppĂ© diverses approches convergentes de pyrazoles diversement substituĂ©s au moyen de rĂ©actions de couplages croisĂ©s pallado-catalyses sĂ©lectifs et sĂ©quentiels Ă  partir de pyrazoles possĂ©dant diffĂ©rents points d’encrages. Dans la deuxiĂšme partie, nous nous sommes intĂ©ressĂ©s Ă  la synthĂšse de diverses furopyridones en tant qu’analogues de produits naturels possĂ©dant une activitĂ© antifongique, et notamment le Cladobotryal. Dans ce but, diverses alcynylpyridones ont Ă©tĂ© synthĂ©tisĂ©es et mises en jeu dans divers processus de cyclisation pour atteindre de maniĂšre divergente une sĂ©rie de furo[3,2-c]pyridin-4-ones, furo[3,2-c]pyridin-6-ones et furo[2,3-b]pyridin-4-onesThis thesis is subdivided into two principal parts. The first part is focussed on the synthesis of pyrazole derivatives of agrochemical relevance. Indeed, the pyrazole nucleus is found in numerous compounds possessing interesting biological properties, and notably antifungal activities. Various convergent approaches to diversely substituted pyrazoles have therefore been developed by means of site-selective palladium-catalyzed cross-coupling reactions conducted sequentially on pyrazole scaffolds. In the second part, we have been involved in the synthesis of furopyridones as simplified analogues of natural compounds possessing antifungal activities such as Cladobotryal. Toward this end, various alkynylpyridones have been synthesizes and involved in diverse cyclization processes to access a series of furo[3,2-c]pyridin-4-ones, furo[3,2-c]pyridin-6-ones, and furo[2,3-b]pyridin-4-one
    • 

    corecore